Granules India Limited share price

Key numbers

Market cap

₹ 23,695 Cr

Current price

₹ 868.65

52-week high / low

₹ 924 / 511

Stock P/E

32.3

Book value

₹ 205.2

Dividend yield

0.20%

ROCE

14.6%

ROE

13.5%

Debt to equity

0.30

Sales growth (3 yrs)

5.9%

Profit growth (3 yrs)

4.8%

1-year return

65.8%

About Granules India Limited

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally. It offers paracetamol, metformin, guaifenesin, ibuprofen, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions. In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives. The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral. Granules India Limited was incorporated in 1984 and is headquartered in…

Quarterly results

Consolidated figures in ₹ crores

Peers in Drug Manufacturers - Specialty & Generic

• Sun Pharmaceutical Industries Limited
• Divi's Laboratories Limited
• Torrent Pharmaceuticals Limited
• Zydus Lifesciences Limited
• Cipla Limited
• Laurus Labs Limited
• Mankind Pharma Limited
• Dr. Reddy's Laboratories Limited
• Aurobindo Pharma Limited
• Lupin Limited